โก Quick Summary
The study evaluates the performance of the Chest Tube Learning Synthesis and Evaluation Assistant (CheLSEA), an artificial intelligence decision support system, in providing chest tube management recommendations. The results indicate that CheLSEA can enhance patient care by delivering safe and reliable recommendations, emulating expert-level clinical guidance.
๐ Key Details
- ๐ Participants: 50 adult patients undergoing elective pulmonary resection
- ๐งฉ Study Duration: October 2020 to May 2021
- โ๏ธ Technology: CheLSEA AI decision support system
- ๐ Performance Metrics: 93% accuracy in predicting chest tube removal time
๐ Key Takeaways
- ๐ฉโโ๏ธ Patient Demographics: Majority were female (62%), smokers (83%), with a median age of 73 years.
- ๐ Queries: CheLSEA was queried 174 times during the study.
- โ ๏ธ Safeguard Activation: 21% of queries triggered the safeguard system, primarily due to subcutaneous emphysema.
- ๐ Removal Recommendations: CheLSEA recommended chest tube removal in 9% of cases, with 83% deemed safe.
- โณ Maintenance Recommendations: 77% of maintenance recommendations were made up to the optimal removal time.
- ๐ Accuracy: 93% of removal time predictions were accurate.
- ๐ Clinical Implications: CheLSEA has the potential to improve chest tube management and patient outcomes.
๐ Background
Chest tube management is a critical aspect of postoperative care, particularly following pulmonary resections. Traditional methods can be subjective and inconsistent, leading to potential complications. The integration of artificial intelligence in clinical decision-making offers a promising avenue to enhance the accuracy and safety of chest tube management, ultimately improving patient outcomes.
๐๏ธ Study
This prospective observational trial involved 50 adult patients who underwent elective pulmonary resections. The study aimed to assess the effectiveness of CheLSEA in generating recommendations for chest tube management based on clinical status, digital pleural drainage data, and chest X-ray data. The AI system was designed to provide recommendations for either chest tube removal or maintenance, along with predictions for optimal removal times.
๐ Results
The findings revealed that CheLSEA was queried 174 times, with 21% of these queries activating the safeguard system due to significant clinical concerns. Of the remaining queries, CheLSEA recommended chest tube removal in 9% of cases, with a high safety rate of 83%. Furthermore, the system demonstrated a remarkable 93% accuracy in predicting the appropriate time for chest tube removal, showcasing its potential as a reliable clinical tool.
๐ Impact and Implications
The implications of this study are significant for clinical practice. By providing safe and reliable recommendations, CheLSEA can enhance chest tube management, reduce complications, and improve patient care. This intelligent decision support system represents a step forward in integrating AI into healthcare, paving the way for more advanced applications in various medical fields.
๐ฎ Conclusion
The CheLSEA study highlights the transformative potential of artificial intelligence in clinical decision-making. By emulating expert-level guidance, CheLSEA can significantly improve chest tube management and patient outcomes. As we continue to explore the integration of AI in healthcare, further research is essential to fully realize its benefits and applications.
๐ฌ Your comments
What are your thoughts on the use of AI in clinical decision-making? We would love to hear your insights! ๐ฌ Share your comments below or connect with us on social media:
Chest Tube Learning Synthesis and Evaluation Assistant (CheLSEA): A Prospective Observational Trial of an Intelligent Decision Support System.
Abstract
OBJECTIVE: This study evaluates the performance of an artificial intelligence predictive clinical decision support system (CheLSEA) in generating chest tube management recommendations.
METHODS: From October 2020 to May 2021, 50 adult elective pulmonary resection patients with at least 24 h of chest tube drainage were enrolled in a single-arm, double-anonymized, observational study to evaluate CheLSEA’s performance compared with standard chest tube care. Clinical status, digital pleural drainage data, and chest X-ray data were collected prospectively. For each query, CheLSEA generated a recommendation for chest tube removal or maintenance. If maintenance was recommended, CheLSEA generated a removal time prediction.
RESULTS: Most patients were female (29 of 47, 62%), smokers (39 of 47, 83%), with a median age of 73 (interquartile range [IQR]: 66 to 77) years, who underwent minimally invasive (44 of 47, 94%) lobectomy (41 of 47, 87%) for primary non-small cell lung cancer (35 of 47, 75%). CheLSEA was queried 174 times, 21% (36 of 174) of which triggered the CheLSEA safeguard system, mostly due to grade 3 or increasing subcutaneous emphysema (20 of 36, 56%). CheLSEA recommended chest tube removal in 9% of remaining requests (12 of 138), 83% of which were safe (10 of 12) and 17% of which were premature by โค6 h (2 of 12). The remaining 126 queries were answered with chest tube maintenance recommendations up to the optimal removal time (97 of 126, 77%) or shortly thereafter (29 of 126, 23%; median = 17 h, IQR: 17 to 22). When predicting chest tube removal time, 93% of responses (82 of 88) were accurate.
CONCLUSIONS: CheLSEA provides safe chest tube management recommendations and can potentially enhance care by reliably emulating expert-level clinical guidance.
Author: [‘Arora N’, ‘Klement W’, ‘Japkowicz N’, ‘Jones DG’, ‘Maziak DE’, ‘Seely AJE’, ‘Sundaresan SR’, ‘Villeneuve PJ’, ‘Gilbert S’]
Journal: Innovations (Phila)
Citation: Arora N, et al. Chest Tube Learning Synthesis and Evaluation Assistant (CheLSEA): A Prospective Observational Trial of an Intelligent Decision Support System. Chest Tube Learning Synthesis and Evaluation Assistant (CheLSEA): A Prospective Observational Trial of an Intelligent Decision Support System. 2026; (unknown volume):15569845261425605. doi: 10.1177/15569845261425605